Basenese Lou — SEC insider filings
SEC reporting owner CIK 1809482. 16 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2020-10-26 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 50,000 shares, $91,600 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 45,000 shares @ $1.83 ($82,350) in ENDRA Life Sciences Inc., filed 2021-08-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | Director | 10 | — | 2 legs · 50,000 sh · $91,600 | 9 |
| ClearSign Technologies Corp (CLIR) | Director | 6 | — | — | 6 |
Insider filings — Basenese Lou
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 3,766 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 4,595 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 3,024 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 60,324 @ $0 | EDGAR |
| 2025-10-03 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 24,621 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 34,722 (derivative) @ $0 | EDGAR |
| 2025-07-01 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 5,384 @ $0 | EDGAR |
| 2025-05-27 | 4 | ClearSign Technologies Corp (CLIR) | Grant/award (A): 10,923 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 600 (derivative) @ $0 | EDGAR |
| 2023-02-01 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 6,746 (derivative) @ $0 | EDGAR |
| 2022-03-30 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 74,500 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2021-08-27 | 4 | ENDRA Life Sciences Inc. (NDRA) | Sale (S): 45,000 @ $1.83 · Sale (S): 5,000 @ $1.85 | EDGAR |
| 2021-04-07 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2020-10-26 | 4 | ENDRA Life Sciences Inc. (NDRA) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1809482 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs